𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gastrointestinal stromal tumors: Rationale for surgical adjuvant trials with imatinib

✍ Scribed by Janice N. Cormier; Shreyaskumar R. Patel; Peter W. T. Pisters

Book ID
107546175
Publisher
Current Science Inc.
Year
2002
Tongue
English
Weight
323 KB
Volume
4
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Imatinib as adjuvant therapy for gastroi
Imatinib as adjuvant therapy for gastrointestinal stromal tumors: a systematic review
✍ Munira Essat; Katy Cooper πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 266 KB πŸ‘ 1 views

## Abstract The high risk of recurrence in resected gastrointestinal stromal tumor (GIST) highlights the need for effective adjuvant treatment. This review evaluates the clinical efficacy and safety of imatinib for adjuvant treatment of localized KIT (CD117)‐positive resected GIST. Relevant studies